Clinical and genetic diagnosis and management of Silver-Russell syndrome: Report of four cases
SRS is diagnosed clinically. However, only 60% of cases are genetically confirmed, while most are sporadic. Although SRS is a well-described syndrome, a delayed diagnosis can have grave consequences on a child's growth. Recombinant human growth hormone treatment is often initiated shortly after the diagnosis. The follow-up requires a multidisciplinary approach.
Authors
- Athina Ververi (ORCID: https://orcid.org/0000-0002-8393-4444)
- Charalampos Antachopoulos (ORCID: https://orcid.org/0000-0003-1416-8878)
- Ilektra Toulia
- Dimitrios G. Goulis (ORCID: https://orcid.org/0000-0002-5005-1995)
- Kyriaki Tsiroukidou
- K Kośta
- Alexandros Sotiriadis (ORCID: https://orcid.org/0000-0003-0876-5596)
- Maria G Grammatikopoulou
- Parthena Savvidou
- Vaya Tziaferi
Institutions
- University of Thessaly (GR)
- University of Macedonia (GR)
- Aristotle University of Thessaloniki (GR)
- Papageorgiou General Hospital (GR)
- University Hospital of Larissa (GR)
- Ippokrateio General Hospital of Thessaloniki (GR)
- Hippocration General Hospital (GR)
Publication Details
- Journal
- World Journal of Clinical Pediatrics
- Published
- 2025-03-18
- DOI
- https://doi.org/10.5409/wjcp.v14.i2.100330
- Primary Topic
- Genetic Syndromes and Imprinting
- Type
- article
- Field-Weighted Citation Impact
- 0.00